These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37303506)

  • 1. L1 cell adhesion molecule may be a protective molecule for atrial fibrillation in patients with valvular heart disease.
    Wang D; Hu B; Xu G; Wei R; Liu Z; Wu H; Xu L; Huang S; Hou J
    Heliyon; 2023 Jun; 9(6):e16831. PubMed ID: 37303506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key immune-related genes and immune infiltration in atrial fibrillation with valvular heart disease based on bioinformatics analysis.
    Li S; Jiang Z; Chao X; Jiang C; Zhong G
    J Thorac Dis; 2021 Mar; 13(3):1785-1798. PubMed ID: 33841968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man.
    Lamirault G; Gaborit N; Le Meur N; Chevalier C; Lande G; Demolombe S; Escande D; Nattel S; Léger JJ; Steenman M
    J Mol Cell Cardiol; 2006 Jan; 40(1):173-84. PubMed ID: 16242148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.
    Gaborit N; Steenman M; Lamirault G; Le Meur N; Le Bouter S; Lande G; Léger J; Charpentier F; Christ T; Dobrev D; Escande D; Nattel S; Demolombe S
    Circulation; 2005 Jul; 112(4):471-81. PubMed ID: 16027256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing left atrial function in patients with atrial fibrillation and valvular heart disease using cardiovascular magnetic resonance imaging.
    Hou J; Sun Y; Zhang L; Wang W; You H; Zhang R; Yang B; Wang H
    Clin Cardiol; 2022 May; 45(5):527-535. PubMed ID: 35289415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinus Rhythm Conduction Properties across Bachmann's Bundle: Impact of Underlying Heart Disease and Atrial Fibrillation.
    Teuwen CP; Does LJMEV; Kik C; Mouws EMJP; Lanters EAH; Knops P; Taverne YJHJ; Bogers AJJC; de Groot NMS
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32560096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of Prediction Model for Atrial Fibrillation with Valvular Heart Disease Based on Machine Learning.
    Li Q; Lei S; Luo X; He J; Fang Y; Yang H; Liu Y; Deng CY; Wu S; Xue YM; Rao F
    Rev Cardiovasc Med; 2022 Jul; 23(7):247. PubMed ID: 39076905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum N-terminal-pro-brain natriuretic peptide level and its clinical implications in patients with atrial fibrillation.
    Bai M; Yang J; Li Y
    Clin Cardiol; 2009 Dec; 32(12):E1-5. PubMed ID: 20014208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram to predict left atrial appendage thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients.
    Sun S; Su B; Lin J; Zhao C; Ma C
    BMC Cardiovasc Disord; 2022 Jul; 22(1):311. PubMed ID: 35820838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial strain for predicting recurrence in patients with non-valvular atrial fibrillation after catheter ablation: a single-center two-dimensional speckle tracking retrospective study.
    Li Y; Li Y; Sun L; Ye X; Cai Q; Zhu W; Guo D; Ding X; Wang J; Lv X
    BMC Cardiovasc Disord; 2022 Nov; 22(1):468. PubMed ID: 36335294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease.
    Chen JQ; Zeng X; Li KC; Huang JL; Guo BL; Zhou X
    J Thorac Dis; 2023 Feb; 15(2):611-619. PubMed ID: 36910075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study.
    Kumarathurai P; Mouridsen MR; Mattsson N; Larsen BS; Nielsen OW; Gerds TA; Sajadieh A
    Europace; 2017 Mar; 19(3):364-370. PubMed ID: 27194537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    De Caterina R; Renda G; Carnicelli AP; Nordio F; Trevisan M; Mercuri MF; Ruff CT; Antman EM; Braunwald E; Giugliano RP
    J Am Coll Cardiol; 2017 Mar; 69(11):1372-1382. PubMed ID: 28302288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Occurrence of Valvular Atrial Fibrillation: Involvement of NGF/TrKA Signaling Pathway.
    Wang Q; Zhao Y; Dong X; Li C; Zhou L; Zou C; Li X; Zhou N; Liu J; Sun Y; Wang J
    J Invest Surg; 2021 Dec; 34(12):1379-1386. PubMed ID: 32781864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
    Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
    Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.